Article
Precision Molecular Diagnosis Defines Specific Therapy in Combined Immunodeficiency with Megaloblastic Anemia Secondary to MTHFD1 Deficiency.
The journal of allergy and clinical immunology. In practice - 1 Jan 2000
Ramakrishnan Kesava A, Pengelly Reuben J, Gao Yifang, Morgan Mary, Patel Sanjay V, Davies E Graham, Ennis Sarah, Faust Saul N, Williams Anthony P
Abstract excerpt
BACKGROUND: Methylenetetrahydrofolate dehydrogenase (MTHFD1) deficiency has recently been reported to cause a folate-responsive syndrome displaying a phenotype that includes megaloblastic anemia and severe combined immunodeficiency. OBJECTIVE: To describe our investigative approach to the molecular diagnosis and evaluation of immune dysfunction in a family with MTHFD1 deficiency. METHODS: The methods used were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
